ANIXA BIOSCIENCES INC (ANIX) Fundamental Analysis & Valuation

NASDAQ:ANIX • US03528H1095

Current stock price

2.65 USD
-0.12 (-4.33%)
At close:
2.65 USD
0 (0%)
After Hours:

This ANIX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ANIX Profitability Analysis

1.1 Basic Checks

  • In the past year ANIX has reported negative net income.
  • ANIX had a negative operating cash flow in the past year.
  • ANIX had negative earnings in each of the past 5 years.
  • ANIX had a negative operating cash flow in each of the past 5 years.
ANIX Yearly Net Income VS EBIT VS OCF VS FCFANIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -67.67%, ANIX is doing worse than 62.09% of the companies in the same industry.
  • ANIX has a Return On Equity (-68.37%) which is in line with its industry peers.
Industry RankSector Rank
ROA -67.67%
ROE -68.37%
ROIC N/A
ROA(3y)-54.85%
ROA(5y)-49%
ROE(3y)-58.39%
ROE(5y)-51.7%
ROIC(3y)N/A
ROIC(5y)N/A
ANIX Yearly ROA, ROE, ROICANIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ANIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANIX Yearly Profit, Operating, Gross MarginsANIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ANIX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ANIX has more shares outstanding
  • ANIX has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for ANIX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ANIX Yearly Shares OutstandingANIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ANIX Yearly Total Debt VS Total AssetsANIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • ANIX has an Altman-Z score of 332.56. This indicates that ANIX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ANIX (332.56) is better than 99.61% of its industry peers.
  • ANIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 332.56
ROIC/WACCN/A
WACCN/A
ANIX Yearly LT Debt VS Equity VS FCFANIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • ANIX has a Current Ratio of 12.18. This indicates that ANIX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 12.18, ANIX belongs to the best of the industry, outperforming 86.07% of the companies in the same industry.
  • ANIX has a Quick Ratio of 12.18. This indicates that ANIX is financially healthy and has no problem in meeting its short term obligations.
  • ANIX's Quick ratio of 12.18 is amongst the best of the industry. ANIX outperforms 86.07% of its industry peers.
Industry RankSector Rank
Current Ratio 12.18
Quick Ratio 12.18
ANIX Yearly Current Assets VS Current LiabilitesANIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ANIX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.38% over the past year.
EPS 1Y (TTM)15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ANIX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.92% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0.91%
EPS Next 2Y0.46%
EPS Next 3Y-4.36%
EPS Next 5Y4.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ANIX Yearly Revenue VS EstimatesANIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2021 2023 2029 2030 2031 2032 2033 200M 400M 600M
ANIX Yearly EPS VS EstimatesANIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. ANIX Valuation Analysis

4.1 Price/Earnings Ratio

  • ANIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANIX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANIX Price Earnings VS Forward Price EarningsANIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANIX Per share dataANIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • A cheap valuation may be justified as ANIX's earnings are expected to decrease with -4.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.46%
EPS Next 3Y-4.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ANIX Dividend Analysis

5.1 Amount

  • No dividends for ANIX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ANIX Fundamentals: All Metrics, Ratios and Statistics

ANIXA BIOSCIENCES INC

NASDAQ:ANIX (3/20/2026, 4:06:13 PM)

After market: 2.65 0 (0%)

2.65

-0.12 (-4.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-09
Earnings (Next)05-26
Inst Owners15.54%
Inst Owner Change9.24%
Ins Owners2.5%
Ins Owner Change3.04%
Market Cap88.85M
Revenue(TTM)N/A
Net Income(TTM)-10.31M
Analysts82
Price Target10.2 (284.91%)
Short Float %3.73%
Short Ratio6.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.3%
Min EPS beat(2)-0.84%
Max EPS beat(2)17.44%
EPS beat(4)3
Avg EPS beat(4)13.03%
Min EPS beat(4)-0.84%
Max EPS beat(4)23.75%
EPS beat(8)5
Avg EPS beat(8)7.24%
EPS beat(12)8
Avg EPS beat(12)8.68%
EPS beat(16)11
Avg EPS beat(16)11.86%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.89
P/tB 5.89
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -67.67%
ROE -68.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.85%
ROA(5y)-49%
ROE(3y)-58.39%
ROE(5y)-51.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.18
Quick Ratio 12.18
Altman-Z 332.56
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y0.91%
EPS Next 2Y0.46%
EPS Next 3Y-4.36%
EPS Next 5Y4.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.38%
OCF growth 3YN/A
OCF growth 5YN/A

ANIXA BIOSCIENCES INC / ANIX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ANIXA BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 3 / 10 to ANIX.


What is the valuation status of ANIXA BIOSCIENCES INC (ANIX) stock?

ChartMill assigns a valuation rating of 0 / 10 to ANIXA BIOSCIENCES INC (ANIX). This can be considered as Overvalued.


Can you provide the profitability details for ANIXA BIOSCIENCES INC?

ANIXA BIOSCIENCES INC (ANIX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ANIX stock?

The Earnings per Share (EPS) of ANIXA BIOSCIENCES INC (ANIX) is expected to grow by 0.91% in the next year.